Evan's Crew: Towards a cure for DIPG
Research Fund
Evan T. Mandeville Research Fund: DIPG Report
Reprinted with permission from Dana-Farber Cancer Institute. To learn more, visit www.dana-farber.org."
Progress
We've established the Evan T. Mandeville DIPG Research Fund at Dana-Farber Cancer Institute in memory of our son Evan who, on November 13, 2012, lost his battle to Diffuse Intrinsic Pontine Glioma (DIPG). He was just 11 years old.
Evan participated in two clinical trials during his exactly one year battle. Clinical trials are the ONLY hope for this devastating diagnosis. We are doing what we can to support efforts to find a cure for DIPG; this rare, always fatal and under-funded pediatric brain tumor.
100% of all donations made through the Pan-Mass Challenge go directly to Evan's research fund.
Thank-you !!!
DIPG Research at Dana-Farber:
Dr. Mark Kiernan, MD, Ph.D
Pediatric Neuro-Oncologist speaking to the importance of funding.
Raised to date*
$1.8 Million
2024: $155,516
2023: $198,212
2022: $231,092
2021: $156,104
2020: $134,512
2019: $196,428
2018: $171,533
2017: $140,921
2016: $154,454
2015: $119,416
2014: $104,289
2013: $80,206
*PMC and direct fund donations